Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Nov 10;7(1):176.
doi: 10.1186/s40478-019-0834-z.

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading

Affiliations
Meta-Analysis

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading

Arnault Tauziède-Espariat et al. Acta Neuropathol Commun. .
No abstract available

Keywords: Astroblastoma; HGNET; MN1; Meta-analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest directly related to the topic of this article.

Figures

Fig. 1
Fig. 1
Results of the meta-analysis and prognostic data of HGNET-MN1. (a) Integrative annotation of histopathologic features (mitotic index, microvascular proliferation -MVP- and necrosis), treatment (surgery and adjuvant therapy -adj. Therapy-) and follow-up of our cases and cases of the literature included in the meta-analysis (b) There is no significant difference in terms of PFS and OS between HGNET-MN1 with or without elevated mitotic index (p = 0.094 and 0.461 respectively), microvascular proliferation (p = 0.379 and 0.423, respectively) and necrosis (p = 0.301 and 0.426, respectively).(c) Results of the meta-analysis including 32 ependymomas, RELA-fusion (EPN-RELA, n = 32), HGENT-MN1 (n = 24), 19 ependymomas, YAP1-fusion (EPN-YAP1, n = 19), and HGNET-BCOR (n = 28). Kaplan–Meier estimates of overall survival (OS) and progression free survival (PFS) according to DNA-methylation subgroups: There is a significant difference in terms of PFS (p < 0.001) and OS (p < 0.001) between EPN-RELA, EPN-YAP1, HGNET-BCOR and HGNET-MN1

References

    1. Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell. 2016;164:1060–1072. doi: 10.1016/j.cell.2016.01.015. - DOI - PMC - PubMed
    1. Boisseau W, Euskirchen P, Mokhtari K, Dehais C, Touat M, Hoang-Xuan K et al (2019) Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. The Oncologist - PMC - PubMed
    1. Lehman NL, Usubalieva A, Lin T, Allen SJ, Tran QT, Mobley BC, et al. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathol Commun. 2019;7:42. doi: 10.1186/s40478-019-0689-3. - DOI - PMC - PubMed
    1. Wood MD, Tihan T, Perry A, Chacko G, Turner C, Pu C, et al. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities. Brain Pathol Zurich Switz. 2018;28:192–202. doi: 10.1111/bpa.12561. - DOI - PMC - PubMed
    1. Petruzzellis G, Alessi I, Colafati GS, Diomedi-Camassei F, Ciolfi A, Pedace L, et al. Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature Review. Front Genet [Internet]. 2019 [cited 2019 May 24];10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502896/ - PMC - PubMed

MeSH terms